FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to VAR2CSA-drug conjugates having biological activity.
EFFECT: conjugates and pharmaceutical compositions containing such conjugates are intended for use in a method of treating cancer.
22 cl, 24 dwg, 13 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
ANTIBACTERIAL AGENTS | 1999 |
|
RU2246941C2 |
DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
SYNTHESIS OF HALICHONDRINS | 2018 |
|
RU2794176C2 |
CYTOSTATIC AGENTS | 1998 |
|
RU2187499C2 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
SUBSTITUTED BIARYL COMPOUNDS OR SUBSTITUTED PYRIDINES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1997 |
|
RU2195443C2 |
DERIVATIVES OF BENZOFURYLPYRONE, MEDICINAL AGENTS COMPRISING THEREOF AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2199536C2 |
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
SUBSTITUTED BENZOPYRANE DERIVATIVES USED AGAINST ARRHYTHMIA | 2002 |
|
RU2291867C2 |
Authors
Dates
2020-02-21—Published
2014-12-29—Filed